Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Non-Current Assets (2016 - 2020)

Larimar Therapeutics (LRMR) has disclosed Non-Current Assets for 7 consecutive years, with $9.4 million as the latest value for Q3 2019.

  • For the quarter ending Q3 2019, Non-Current Assets rose 1884.03% year-over-year to $9.4 million, compared with a TTM value of $22.5 million through Sep 2019, up 458.93%, and an annual FY2018 reading of $432000.0, down 26.15% over the prior year.
  • Non-Current Assets was $9.4 million for Q3 2019 at Larimar Therapeutics, down from $9.9 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $9.9 million in Q2 2019 and bottomed at $395000.0 in Q1 2015.
  • Average Non-Current Assets over 5 years is $2.0 million, with a median of $996000.0 recorded in 2015.
  • The sharpest move saw Non-Current Assets crashed 47.43% in 2017, then surged 1884.03% in 2019.
  • Year by year, Non-Current Assets stood at $996000.0 in 2015, then decreased by 27.51% to $722000.0 in 2016, then fell by 18.98% to $585000.0 in 2017, then decreased by 26.15% to $432000.0 in 2018, then surged by 2086.11% to $9.4 million in 2019.
  • Business Quant data shows Non-Current Assets for LRMR at $9.4 million in Q3 2019, $9.9 million in Q2 2019, and $2.7 million in Q1 2019.